Feasibility trial of UFT after withdrawal of adjuvant TS-1 with adverse effects in patients with curatively resected gastric cancer.
Not Applicable
Suspended
- Conditions
- Gastric Cancer
- Registration Number
- JPRN-UMIN000001148
- Lead Sponsor
- Division of Gastrointestinal Surgery, Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
administration contraindication of UFT Severe complications, such as paralytic ileus, bowel obstruction, interstitial pneumonitis, pulmonary fibrosis, regular use of insulin or uncontrollable diabetes mellitus, arrhythmias, heart failure, liver cirrhosis, and active hepatitis) Severe watery diarrhea. HIV+ Exclude the patients who are recognized as inadequate patients by doctors with responsibility in this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility
- Secondary Outcome Measures
Name Time Method Safety of UFT Relapse-Free Survival Overall Survival